Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy N Burrows

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Viruses|July 27, 2022
The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus ReplicationLucca R Policastro, Isabela Dolci, Andre S Godoy, et al.
Parasites & Vectors|June 2, 2017
Assessing the anthelmintic activity of pyrazole-5-carboxamide derivatives against Haemonchus contortusYaqing Jiao, Sarah Preston, Hongjian Song, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2025
Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasitesEmma Y Mao, William Nguyen, Gouranga P Jana, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria ChemoprotectionAnil K Gupta, Anders M Eliasen, Wil Andahazy, et al.
Communications Biology|May 10, 2019
Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquoneTina S Skinner-Adams, Gillian M Fisher, Andrew G Riches, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2011
Cyclopropyl carboxamides, a chemically novel class of antimalarial agents identified in a phenotypic screenLaura M Sanz, M Belen Jiménez-Díaz, Benigno Crespo, et al.
Journal of Medicinal Chemistry|August 23, 2014
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of PlasmodiumR Matthew Cross, David L Flanigan, Andrii Monastyrskyi, et al.
Molecular Pharmacology|July 7, 2022
Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial LeadsMichelle M Butler, Samanthi L Waidyarachchi, Jinfeng Shao, et al.
ACS Omega|September 11, 2018
Isoxazolopyrimidine-Based Inhibitors of Sreekanth Kokkonda, Farah El Mazouni, Karen L White, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 17, 2023
Development and application of a PBPK modeling strategy to support antimalarial drug developmentNada Abla, Eleanor Howgate, Karen Rowland-Yeo, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Viruses|July 27, 2022
The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus ReplicationLucca R Policastro, Isabela Dolci, Andre S Godoy, et al.
Parasites & Vectors|June 2, 2017
Assessing the anthelmintic activity of pyrazole-5-carboxamide derivatives against Haemonchus contortusYaqing Jiao, Sarah Preston, Hongjian Song, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2025
Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasitesEmma Y Mao, William Nguyen, Gouranga P Jana, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria ChemoprotectionAnil K Gupta, Anders M Eliasen, Wil Andahazy, et al.
Communications Biology|May 10, 2019
Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquoneTina S Skinner-Adams, Gillian M Fisher, Andrew G Riches, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2011
Cyclopropyl carboxamides, a chemically novel class of antimalarial agents identified in a phenotypic screenLaura M Sanz, M Belen Jiménez-Díaz, Benigno Crespo, et al.
Journal of Medicinal Chemistry|August 23, 2014
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of PlasmodiumR Matthew Cross, David L Flanigan, Andrii Monastyrskyi, et al.
Molecular Pharmacology|July 7, 2022
Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial LeadsMichelle M Butler, Samanthi L Waidyarachchi, Jinfeng Shao, et al.
ACS Omega|September 11, 2018
Isoxazolopyrimidine-Based Inhibitors of Sreekanth Kokkonda, Farah El Mazouni, Karen L White, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 17, 2023
Development and application of a PBPK modeling strategy to support antimalarial drug developmentNada Abla, Eleanor Howgate, Karen Rowland-Yeo, et al.
Pageof 9